NO904839L - Fremgangsmaate for fremstilling av benzoxazinderivater. - Google Patents

Fremgangsmaate for fremstilling av benzoxazinderivater.

Info

Publication number
NO904839L
NO904839L NO90904839A NO904839A NO904839L NO 904839 L NO904839 L NO 904839L NO 90904839 A NO90904839 A NO 90904839A NO 904839 A NO904839 A NO 904839A NO 904839 L NO904839 L NO 904839L
Authority
NO
Norway
Prior art keywords
procedure
benzoxazine derivatives
preparing benzoxazine
preparing
derivatives
Prior art date
Application number
NO90904839A
Other languages
English (en)
Norwegian (no)
Other versions
NO904839D0 (no
Inventor
Yuzo Matsumoto
Ryuji Tsuzuki
Akira Matsuhisa
Kazuhisa Takayama
Wataru Uchida
Masaharu Asano
Toru Yoden
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO904839D0 publication Critical patent/NO904839D0/no
Publication of NO904839L publication Critical patent/NO904839L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90904839A 1989-11-08 1990-11-07 Fremgangsmaate for fremstilling av benzoxazinderivater. NO904839L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP29072789 1989-11-08
JP31592689 1989-12-05
JP34293789 1989-12-28
JP20854890 1990-08-06

Publications (2)

Publication Number Publication Date
NO904839D0 NO904839D0 (no) 1990-11-07
NO904839L true NO904839L (no) 1991-05-10

Family

ID=27476415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904839A NO904839L (no) 1989-11-08 1990-11-07 Fremgangsmaate for fremstilling av benzoxazinderivater.

Country Status (11)

Country Link
EP (1) EP0432893A3 (mo)
JP (1) JPH0774208B2 (mo)
KR (1) KR950007757B1 (mo)
AU (1) AU641953B2 (mo)
FI (1) FI905510A7 (mo)
HU (1) HU211282A9 (mo)
IE (1) IE904013A1 (mo)
NO (1) NO904839L (mo)
PH (1) PH30439A (mo)
PT (1) PT95798A (mo)
TW (1) TW224941B (mo)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
CN1060467A (zh) * 1990-09-25 1992-04-22 武田药品工业株式会社 1，3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
JPH06220029A (ja) * 1992-12-03 1994-08-09 Ss Pharmaceut Co Ltd １，４−ベンズオキサジン誘導体
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
WO1994018195A1 (fr) * 1993-02-05 1994-08-18 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de benzoxazine, medicament le contenant, et son intermediaire
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
CN1109880A (zh) * 1994-02-03 1995-10-11 合成实验室公司 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用
CN1065529C (zh) * 1994-06-09 2001-05-09 爱斯制药株式会社 4－喹啉酮衍生物及其盐
US6218411B1 (en) * 1997-08-08 2001-04-17 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
KR100466809B1 (ko) * 1998-06-30 2006-01-27 씨제이 주식회사 즉석닭튀김식품의제조방법
AU5444499A (en) * 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
JPWO2002072049A1 (ja) * 2001-02-27 2004-07-02 山之内製薬株式会社 育毛用医薬組成物
WO2002085868A1 (en) * 2001-04-23 2002-10-31 Astrazeneca Ab Benzoxazinone derivatives for use in the treatment of angiogenesis
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
IL166241A0 (en) 2002-07-29 2006-01-15 Rigel Pharmaceuticals Inc Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds
ES2421139T3 (es) 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
RU2372344C2 (ru) * 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого
AU2005291541B2 (en) * 2004-09-30 2011-03-10 F. Hoffmann-La Roche Ag Benzoxazine and quinoxaline derivatives and uses
US7378415B2 (en) 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
US7449458B2 (en) 2005-01-19 2008-11-11 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
JP5306821B2 (ja) 2005-12-30 2013-10-02 ノバルティス アーゲー レニン阻害剤としての３，５−置換ピペリジン化合物
WO2007086504A1 (ja) * 2006-01-27 2007-08-02 Japan Tobacco Inc. カルボン酸化合物及びその用途
TWI385161B (zh) 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
KR101411695B1 (ko) 2006-02-17 2014-07-03 리겔 파마슈티칼스, 인크. 자가면역 질환의 치료 또는 예방을 위한 2,4-피리미딘디아민 화합물
IN2014CN04174A (mo) 2011-12-22 2015-09-04 Novartis Ag
CN115181264B (zh) * 2022-07-20 2023-05-23 中国航空工业集团公司济南特种结构研究所 一种苯并噁嗪中间体及其制备方法和聚苯并噁嗪树脂制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595863C3 (de) * 1966-08-11 1978-03-02 Knoll Ag, 6700 Ludwigshafen 4-Piperidinoacetyl-3,4-dihydro-(2H)-l,4-benioxazin und Verfahren zu dessen Herstellung
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
JPS61215381A (ja) * 1985-03-22 1986-09-25 Ube Ind Ltd ベンゾオキサジン誘導体および除草剤
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
EP0290863A3 (en) * 1987-05-09 1989-03-15 Nihon Tokushu Noyaku Seizo K.K. Benzoxazine derivative, process and intermediates for its preparation and its use as herbicide
EP0298542B1 (en) * 1987-07-07 1990-12-12 Shell Internationale Researchmaatschappij B.V. Process for preparing thiophene derivatives
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
AU641953B2 (en) 1993-10-07
AU6594790A (en) 1991-06-06
KR910009682A (ko) 1991-06-28
JPH0774208B2 (ja) 1995-08-09
HU211282A9 (en) 1995-11-28
NO904839D0 (no) 1990-11-07
JPH04178375A (ja) 1992-06-25
IE904013A1 (en) 1991-05-08
KR950007757B1 (ko) 1995-07-14
FI905510A0 (fi) 1990-11-07
FI905510A7 (fi) 1991-05-09
PT95798A (pt) 1991-09-13
PH30439A (en) 1997-05-09
EP0432893A3 (en) 1991-07-10
TW224941B (mo) 1994-06-11
EP0432893A2 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
NO964871L (no) Nye agonistforbindelser
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
MY102016A (en) Thiazolidinedione derivatives, their production and use.
NO862426D0 (no) Fremgangsmaate for fremstilling av pyridobenzoksazinderivater.
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
NO179674C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, heterosykliske N-oksidderivater av substituerte benzo[5,6Åsyklo-heptapyridiner
NO173139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
NO178858C (no) Analogifremgangsmåte for fremstilling av substituerte 4-fenyl-4-piperidinkarboksamider med både lokal anestetisk og analgetisk effekt
NO880731D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
DE69011913D1 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung.
NO882334D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
NO870998D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater.
NO172490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
NO171722C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye tetralinderivater
NO20013601L (no) Nye morfolinobenzamidsalter
NO893784L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktiveimidazolderivater.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
NO883263D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater.
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
NO890691L (no) Fremgangsmaate for fremstilling av nye basiske substituerte 5-halogen-tienoisotiazol-3(2h)-on-1,1-dioksider og farmasoeytiske preparater derav.
NO873571L (no) Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.